FDA Gleans Compounding Funding Bump With Efficiencies, Research Cuts

FDA was able to add $25 million to its budget for compounding oversight by increasing administrative efficiencies and trimming research and outreach activities, the agency said.

Quoted from insidehealthpolicy.com